
    
      Pediatric patients diagnosed with Complex Congenital Heart Disease ready to accept scheduled
      open-heart surgery under cardiopulmonary bypass (CPB).

      This study uses randomized (centralized randomization) & controlled design with open label.
      Eligible subjects will be randomized to receive either study drug (Ulinastatin) or
      conventional treatment.
    
  